GFAP and acute myeloid leukemia: Therefore, to elucidate AML pathogenesis and find novel targeted therapy, we detected the expression of nerve-related factors [nestin, tyrosine hydroxylase (TH), GFAP and S100B] in BM of AML patients to explore the role of nerve injury in the development of AML.